Searched for
COVID DRUGS DEMAND
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Saving supply chains from climate shocks is a lure for investorsCompanies are increasingly focused on supply chain resilience. This trend is expected to continue, offering new opportunities and protectin...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Strait of Hormuz is now India's biggest market risk, says Ashi AnandIndian markets await clarity on Strait of Hormuz shipping. Ashi Anand of IME Capital suggests a defensive market approach. Oil prices near ...
- Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
- Demand for Indian generic drugs skyrockets in China amid massive Covid surgeChina's National Health Security Administration said on Sunday that Pfizer's Paxlovid oral medication, which is used to treat Covid-19, cou...
- Companies stare at huge losses as unsold Covid drugs pile upDuring the past two years, there were sky-rocketing sales of Covid-19 portfolio of drugs, sometimes even severe shortages. But now the indu...
- Demand for Covid drugs down, says Cipla Global CFOThe third wave has been fuelled by the Omicron variant, which is highly infectious yet milder, causing flu-like symptoms such as fever, bod...
- Black fungus scare: Govt engaging with drug makers to ramp up production of anti-fungal drugWith a spike in the cases of COVID-19 in the country, doctors have been reporting a rare infection mucormycosis, also called as black fungu...
- Roche India gets emergency use approval for antibody cocktail used in COVID-19 treatmentRoche said that the production process for this drug is “very complex” and the company will do everything to ensure an equitable distributi...
- Roche to boost Tocilizumab supply to meet rising demand in IndiaThe cost of the drug in India is upwards of ₹50,000 per vial. However, due to shortage the drug has been selling at exorbitant prices accor...
- Government bans export of Remdesivir till Covid-19 situation improvesA state health department official said the state has more stock than that. Maharashtra is also planning to put a ban on the retail sale of...
- Scaled up remdesivir production two-fold: Cipla"We have scaled up the production of remdesivir by 2x from the last wave of the pandemic. Given the unprecedented demand for the drug, we h...
- Cipla doubles remdesivir production to meet 'unprecedented' demand"We have scaled up the production of remdesivir by 2x from the last wave of the pandemic," Cipla said in a statement. "Given the unpreceden...
- View: Drug abuse affects more people than Covid yet we bury the issueIf you believe that drug abuse can’t be compared to the Covid-19 pandemic, do browse through India’s first-ever large-scale, nationwide sur...
- Indiscriminate use led to bogus tocilizumab injections: FDCAThe patented drug is manufactured only by Switzerland-based Roche Pharma and marketed in India by Cipla, he said, adding that since May, as...
- Call for patent removal, price cut of Covid-19 drugs and diagnosticsOver 20 civil society groups working on health rights have written to government to encourage innovation, remove patent barriers and bring ...
- Gilead under gun to mass-produce virus drug or risk exclusivityAll of that could add up to market wins if remdesivir lives up to expectations and Gilead can ramp up to sufficiently respond to Covid-driv...
- Mumbai based IPCA gets a shot in the arm as USFDA suspends import ban for key Covid-19 drugIPCA has a market share of nearly 70% of these drugs, as it is one of the largest suppliers of the active pharmaceutical ingredient of thes...
Load More
